chemotherapy

Antibody Drug Conjugate Prolongs Life in NSCLC refractory to EGFR TKI Therapy

“Adjuvant nivolumab added to chemoradiotherapy after surgery provided a statistically and clinically meaningful disease-free survival improvement in PD-L1 all-comers patients. This is the first time i

Nick Thatcher NICK THATCHER, Christie Hospital, Manchester There is a proven benefit in survival if you give your patients cis-platinum based chemotherapy after resection for non-small cell lung cance

Timothy Illidge Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008 TIMOTHY ILLIDGE, Christie Hospital, Manchester Radioconjugated antibodies are showing grea

David Cunningham REFERENCE: Abstract 3012, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 DAVID CUNNINGHAM, Royal Marsden Hospital, London The oral agent capeticabine

Charles Hsu CHARLES HSU, Johns Hopkins University, Baltimore Big improvements in overall survival were achieved by combining radiation with adjuvant chemotherapy for patients with pancreas cancer in a

Susan O’Brien SUSAN O’BRIEN, MD Anderson Cancer Center, Houston For patients with relapsed or refractory CLL, oblimersen extends survival when added to standard fludarabine/cyclophosphamid

Jean-Yves Douillard Gordon McVie REFERENCE: Abstracts: 6507 & 2LB, ECCO 14, The European Cancer Conference, Barcelona, 23 Р27 September 2007 JEAN-YVES DOUILLARD, Centre Ren̩ Gauducheau, N

Jose Baselga Gordon McVie REFERENCE: ABSTRACT 2030, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007 JOSE BASELGA, Vall d’Hebron University Hospital, Barcelona CO

Pedro Cahn REFERENCE: Abstract H-717, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 PEDRO CAHN, Juan A. Fernández Hospital, Buenos Aires Etraviri

Lindsay Grayson REFERENCE: Abstract K-1374, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 LINDSAY GRAYSON, Austin Hospital, Victoria, Australia A

Megan Nguyen REFERENCE: Poster Session 104 K-1096, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 MEGAN NGUYEN, Western University in Pomona, Calif

Jon Otter REFERENCE: Poster Session 033 K-464, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JON OTTER, Bioquell Ltd, Andover UK An investigation

Paul Fisher REFERENCE: Meet the Professor Session, AACR 2007, Los Angeles PAUL FISHER, Columbia University, New York Patients with cancer could soon be treated with adenoviruses capable of infecting b

&ot&uot Kate Stern REFERENCE: O-144 KATE STERN, Royal Women’s Hospital, Melbourne A potential new way of preserving ovarian function during chemotherapy for cancer could be treatment w

Ariel Revel Eggs From Young Patients Before Chemotherapy: New Hope for Future Fertility REFERENCE: ABSTRACT Oral 107, ESHRE Annual Meeting Lyon July 1-4, 2007 ARIEL REVEL, Hadassah University Hospital

George Canellos Robert Motzer Hormone Replacement Therapy: Better Survival With Colorectal Cancer REFERENCE: J Clin Oncol 24:5680-5686 GEORGE CANELLOS, Dana-Farber Cancer Institute, Boston Using postm

Daniel Petrylak Oliver Sartor Mark Socinski Kanti Rai Edward Ambinder Chemo- and Immunotherapy Working Together in Hormone Refractory Prostate Cancer REFERENCE: Chemotherapy Foundation Symposium XXIV

David Cameron Martine Piccart Eric Van Cutsem Jim Cassidy Volker Heinemann Lapatinib Better for Patients with HER2+ Refractory Breast Cancer Pre-treated with Chemotherapy and Trastuzumab REFERENCE: ES

Gordon McVie Martine Piccart Bella Kaufman Jean-Yves Douillard ESMO Congress Reviewed GORDON MCVIE, European Institute of Oncology, Milan In Istanbul, Gordon McVie gave his opinion about the achieveme

John Neoptolemos Wilko Weichert Christophe Nemos Pancreatic Cancer: Adjuvant Chemotherapy Improves Outlook for Patients with Resectable Tumors – ESPAC Trial Results REFERENCE: National Cancer Re

David Cunningham Kenneth MacDonald Mark Pomerantz Jorge Garcia REFERENCE: N Engl J Med 2006;355:11 David Cunningham, Royal Marsden Hospital The July 6th edition of the New England Journal of Me

Better Combine Chemotherapy with Radiation for Hodgkin’s Disease? Joachim Yahalom George Canellos REFERENCE: Education Session: Saturday June 3rd, 2006 ASCO Annual Meeting, June 2-6, Atla

Arlene Forastiere Everett Vokes Michael Skinner Mark Chambers Larynx Cancer: Concurrent Chemoradiotherapy: Best for Larynx Preservation REFERENCE: Abstract 5517 Arlene Forastiere, Sidney Kimmel Compre

George Canellos Carmela Pepe John Goldman Roy Herbst Sandra Horning George Canellos, from the Dana-Farber Cancer Institute in Boston, joins Derek Thorne to talk about the first day’s news at the

Dennis Slamon, UCLA School of Medicine, Los Angeles It may be reasonable to replace the anthracycline component of adjuvant chemotherapy with carboplatin in HER-2 positive patients with early breast c